Lord, Abbett & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$338M |
| 2 |
UnitedHealth
UNH
|
+$140M |
| 3 |
ExxonMobil
XOM
|
+$134M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$122M |
| 5 |
Verizon
VZ
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$274M |
| 2 |
HP
HPQ
|
+$176M |
| 3 |
McKesson
MCK
|
+$172M |
| 4 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$169M |
| 5 |
Prudential Financial
PRU
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.07% |
| 2 | Healthcare | 14.16% |
| 3 | Technology | 13.06% |
| 4 | Industrials | 12.52% |
| 5 | Consumer Discretionary | 10.19% |
Similar funds
Lord, Abbett & Co's Q1 2015 Portfolio in Review
As of Q1 2015, Lord, Abbett & Co held 1,026 positions worth $39.5B, up 0.15% from $39.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Lord, Abbett & Co withdrew a net $2.29B in Q1 2015, closing 133 positions and reducing 359 holdings. Its most notable exit was POLYPORE INTERNATIONAL, INC, an estimated $85M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Lord, Abbett & Co opened a new position in ACTAVIS PLC Pfd Conv Ser A (Irl) worth $76.9M.
- Lord, Abbett & Co's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 75,968 shares worth $76.9M.
- Lord, Abbett & Co added most to Pfizer in Q1 2015, an estimated $338M increase.
- Lord, Abbett & Co's biggest Q1 2015 reduction was Bristol-Myers Squibb, cutting an estimated $274M.
- Lord, Abbett & Co fully exited POLYPORE INTERNATIONAL, INC in Q1 2015, selling an estimated $85M.
- Lord, Abbett & Co's ten largest holdings make up 11% of its $39.5B portfolio in Q1 2015.
- Lord, Abbett & Co opened 121 new positions and closed 133 in Q1 2015.
- Lord, Abbett & Co's portfolio value rose 0.15% quarter-over-quarter to $39.5B.
Based on Lord, Abbett & Co's 13F filing for Q1 2015, filed 15 May 2015.